Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs

PURPOSE: Triple negative (TN) breast cancers which lack expression of the estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2) receptors convey a poor prognosis due in part to a lack of targeted therapies. METHODS: To identify viable targets for the treatment of TN disease, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Scooter, De, Pradip, Dey, Nandini, Long, Bradley, Young, Brandon, Sparano, Joseph A., Wang, Victoria, Davidson, Nancy E., Leyland-Jones, Brian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436509/
https://www.ncbi.nlm.nih.gov/pubmed/26005638
http://dx.doi.org/10.1016/j.mgene.2015.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436509/
https://www.ncbi.nlm.nih.gov/pubmed/26005638
http://dx.doi.org/10.1016/j.mgene.2015.04.002

Ejemplares similares